Composition for nursing in perioperative period of ophthalmology department

By using a composition of modified chitosan and natural extracts, the perioperative eye drops of ophthalmic care were prepared, which solved the problems of high cost and great side effects of eye drops in the prior art, and achieved effective treatment for pathogenic bacteria Inhibition and repair of corneal injury, suitable for large-scale promotion.

CN118903371AInactive Publication Date: 2024-11-08THE SECOND XIANGYA HOSPITAL OF CENT SOUTH UNIV

Patent Information

Application Number
CN202411309105.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-19
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In the existing perioperative ophthalmic care, antibiotics or hormone eye drops have problems such as high cost, high side effects and difficulty in large-scale promotion. Long-term use may undermine the ecological balance of the eye and lead to drug resistance.

Method used

A natural preparation is prepared by modifying the combination of chitosan and extract using a composition of chitosan, dandelion extract, honeysuckle extract, hyaluronic acid, astaxanthin, threxatin and glutathione. Ophthalmic perioperative eye drops avoid antibiotics, hormones and preservatives.

Benefits of technology

It has achieved strong inhibition of common pathogenic bacteria and effective repair of corneal injury, reduced side effects, and was low in cost, suitable for large-scale promotion, and has good antibacterial and anti-inflammatory effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903371A_ABST
    Figure CN118903371A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of ophthalmologic perioperative period nursing, and discloses a composition for ophthalmologic perioperative period nursing, which is prepared from the following ingredients in parts by weight: 100 parts of chitosan, 5 to 10 parts of herba taraxaci extracts, 4 to 8 parts of honeysuckle flower extracts, 3 to 6 parts of hyaluronic acid, 1 to 2 parts of astaxanthin, 1 to 2 parts of tremella polysaccharide and 1 to 1.5 parts of glutathione. The invention also discloses an application of the composition in preparation of eye drops. Furthermore, the invention further discloses eye drops prepared from the composition and used for ophthalmology perioperative period nursing and a preparation method of the eye drops. Compared with the prior art, the composition / eye drops for nursing in the perioperative period of the ophthalmology department have the advantages that the raw materials are natural and easy to obtain, antibiotics, hormones and preservatives are not contained, the antibacterial and anti-inflammatory effects are good, and the composition / eye drops have a good promoting effect on cornea repair in the perioperative period of the ophthalmology department and have a good application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of ophthalmic perioperative care, and particularly relates to a composition for ophthalmic perioperative care. Background Art

[0002] Endophthalmitis is a common complication after ophthalmic surgery, 90% of which are caused by bacteria. Among all cases of infection, 2 / 3 occur after surgery, most of which are cataract surgeries. Allen et al. reported 30,000 cataract surgeries, with an incidence of postoperative infectious endophthalmitis of 0.057%. The source of the bacteria of infection has a certain regularity. For example, after cataract surgery, most of them are Staphylococcus epidermidis, and the prognosis is generally good. Traumatic infectious endophthalmitis accounts for about 20-30% of all cases of infectious endophthalmitis, which is the second most common cause of infectious endophthalmitis. The incidence after perforation of the eyeball is as low as 2% and as high as 7.4%. The risk of infectious endophthalmitis in patients with foreign bodies in the eyeball is twice that of cases without foreign bodies in the eyeball. Its pathophysiological basis is as follows: the vitreous is an excellent growth base for bacteria and microorganisms. After pathogenic bacteria invade the vitreous, they can multiply rapidly and cause inflammatory reactions. The degree of pathological changes in endophthalmitis is related to the number and virulence of bacteria, the body's immune function and the effect of treatment. In the acute phase, neutrophil infiltration, exudation and tissue necrosis are manifested under the microscope. Neutrophils are diffusely distributed around blood vessels and gather in large numbers in the anterior chamber and vitreous, and are more dense at the site of scleral perforation. If the lens capsule ruptures, pathogenic bacteria and neutrophils can invade the lens, causing lens volume pus. Protein exudates appear in the anterior chamber, posterior chamber and vitreous, and fibrous purulent nodules are formed in the anterior chamber and ciliary body. Necrotic cells swell, lose cell structure, and the nuclei shrink, rupture or disappear. Necrotic tissue is often eosinophilic. Pigment particles are not easily decomposed and destroyed, and are often phagocytosed by macrophages. Ring-shaped necrosis and perforation are formed after the central cornea is infiltrated by toxins or neutrophils. After the acute suppurative inflammation subsides, the infiltrating neutrophils are gradually replaced by monocytes or lymphocytes. The inflammatory exudate is gradually absorbed, often together with granulation tissue to form fibrous scar tissue.

[0003] In view of the above-mentioned causes of disease, antibiotic or hormone eye drops and eye ointments are often used after surgery to prevent infection and inhibit postoperative reactive inflammation. The main function of antibiotic eye drops is to prevent infection and treat bacterial infections of the eye. There are many microorganisms (mainly bacteria, but also fungi, viruses, etc.) that settle, grow and reproduce on the surface of the eye, such as the eyelids and conjunctival sacs. They are called normal flora in medicine. They play an important role in maintaining the ecological balance of the human body and the stability of the internal environment. If antibiotic eye drops are used for a long time, on the one hand, normal bacteria are killed, the ecological balance of the eye is destroyed, and some diseases may occur; on the other hand, bacteria become resistant to drugs. When bacterial infection occurs in the eye and antibiotics are needed, these drugs cannot achieve the original effect. Hormone eye drops have a strong anti-inflammatory effect and can inhibit inflammatory edema, fibrin deposition, capillary dilation, leukocyte migration, scar formation, etc. If hormone eye drops are used for a long time, it can cause increased intraocular pressure, produce hormone-induced glaucoma, damage the optic nerve, lead to decreased vision, visual field defects, and cataracts under the posterior capsule. It may also cause corneal fungal infection. Like antibiotics, long-term use may lead to overgrowth of non-sensitive microorganisms.

[0004] To solve the above problems, patent document CN202010951511.7 discloses an eye care composition, a preparation method and a use thereof, wherein the eye care composition comprises chondroitin sulfate, hyaluronic acid and ectoine or an ophthalmologically acceptable ectoine derivative, wherein in the eye care composition, the mass percentage of chondroitin sulfate is 0.05%-2%, preferably 0.1%-1%, the mass percentage of hyaluronic acid is 0.01%-2.5%, preferably 0.05%-1.5%, and the mass percentage of ectoine or an ophthalmologically acceptable ectoine derivative is 0.5%-5%, preferably 0.5%-2%. The eye care composition of the invention can accelerate the repair of corneal damage by combining hyaluronic acid, ectoine and chondroitin sulfate in a certain weight ratio, has a significant anti-fatigue effect, a fast recovery time for iris congestion and swelling, and has a good inhibitory effect on the growth of Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans. However, after analysis and research, the above technical solution still has certain defects, mainly manifested in the high price of medical-grade ectoine and chondroitin sulfate, high product cost, difficulty in entering medical insurance, and is not conducive to large-scale promotion, and the eye care composition also contains preservatives.

[0005] Therefore, it is necessary to design an eye care composition which is low in cost, can be widely promoted and applied, has few side effects and has good antibacterial effect. Summary of the invention

[0006] The purpose of the present invention is to provide a composition for perioperative care in ophthalmology, so as to solve the problem mentioned in the background art that the current methods of using antibiotic or hormone eye drops and eye ointments to prevent infection after surgery have defects.

[0007] To achieve the above object, the present invention provides a composition for ophthalmic perioperative care, comprising the following components by weight:

[0008] 100 parts of chitosan, 5-10 parts of dandelion extract, 4-8 parts of honeysuckle extract, 3-6 parts of hyaluronic acid, 1-2 parts of astaxanthin, 1-2 parts of tremella polysaccharide and 1-1.5 parts of glutathione.

[0009] In a specific embodiment, the chitosan is secondary modified chitosan, and the specific modification steps of the secondary modified chitosan are as follows:

[0010] S1.1 Primary modification of chitosan: add a chitosan raw material with a deacetylation degree of 90-95% and an average molecular weight of 20000-25000Da and a hydrochloric acid solution with a mass fraction of 1-3% into a reaction container, wherein the mass volume ratio of the chitosan raw material to the hydrochloric acid solution is 1g:25-50mL; control the reaction temperature at 0-5°C in an ice-water bath; add soybean lecithin and dialdehyde starch under stirring; remove the ice-water bath after the addition is complete, and continue stirring the reaction at room temperature for 2-4h; obtain a primary modified chitosan by standing, precipitation, suction filtration, drying, and recrystallization; wherein the mass ratio of the chitosan raw material, soybean lecithin and dialdehyde starch is 1:(0.1-0.2):(0.02-0.3);

[0011] S1.2 Chitosan cross-linking: dissolve the primary modified chitosan in acetic acid solution to prepare a 60-100 mg / mL primary modified chitosan solution, and adjust the pH value to 5.5-6.5; drip 3-6 mg / mL sodium hexametaphosphate solution dropwise into the modified chitosan solution at a volume ratio of 1:(1.0-1.5), add a stabilizer at a final concentration of 2-20 mg / mL to form a cross-linked stable solution; obtain a secondary modified chitosan after standing, precipitation, filtration, drying, and recrystallization.

[0012] In a specific embodiment, the dandelion extract is prepared by the following method:

[0013] S2.1 Water extraction: Take the dried whole dandelion, crush it and pass it through a 60-80 mesh sieve, add distilled water according to the solid-liquid ratio of 1g:25-35mL, soak at 50-70℃ for 30-40min, soak twice, filter, combine the filtrate, concentrate the filtrate 2-3 times, centrifuge and collect the supernatant;

[0014] S2.2 Preliminary purification: The supernatant was filtered through a 0.45 μm pore size filter membrane and ultrasonicated for 5 to 10 minutes, then applied to a pretreated D101 macroporous adsorption resin column, washed with water for 2 column volumes, eluted with 50% to 70% ethanol aqueous solution, the eluate was collected, and the eluate was concentrated 4 to 6 times;

[0015] S2.3 Purification again: The concentrated eluate was extracted with an equal volume of ethyl acetate, the extract was collected and concentrated 5 to 6 times, and then vacuum dried to obtain the dandelion extract.

[0016] In a specific embodiment, the honeysuckle extract is prepared by the following method:

[0017] S3.1 Weigh the dried honeysuckle, add 60%-80% (V / V) ethanol solution, the amount of ethanol solution added is 4-8 times the weight of the dried honeysuckle (V / W), soak for 2-10 hours, heat and reflux for extraction 2-4 times, each reflux extraction for 1.5-3 hours, filter, collect the ethanol extract, adjust the pH of the filtrate to 5.5-8.5, let stand for 2-50 hours, filter, and concentrate the filtrate until there is no alcohol taste, to obtain a honeysuckle concentrate with a relative density of 1.05-1.4, wherein the relative density is measured at 60°C, and the concentration is vacuum concentration;

[0018] S3.2 Cool the honeysuckle concentrate to 4-35°C, filter, add 0.1-0.2 times (V / W) of the weight of dried honeysuckle to the filtrate for extraction, let stand for 0.5-12h, separate and remove the chloroform extract, and dry to obtain the honeysuckle extract, wherein the drying includes reduced pressure drying.

[0019] The present invention also provides the use of the composition for ophthalmic perioperative care as described above, for preparing eye drops for ophthalmic perioperative care.

[0020] In a specific embodiment, the ophthalmic perioperative period is the ophthalmic cataract surgery perioperative period.

[0021] The present invention also provides an eye drop for ophthalmic perioperative care, comprising sterile water and the above-mentioned composition for ophthalmic perioperative care.

[0022] In a specific embodiment, in the eye drops for ophthalmic perioperative care, the mass fraction of the composition for ophthalmic perioperative care is 0.5-2%.

[0023] The present invention also provides a method for preparing the eye drops for ophthalmic perioperative care as described above, comprising the following steps:

[0024] First, chitosan, dandelion extract, honeysuckle extract, hyaluronic acid, astaxanthin, tremella polysaccharide, and glutathione in the formulated amounts are uniformly mixed, and crushed through a 200-mesh sieve to obtain a first mixture;

[0025] Then, the first mixture is added into sterile water at 0.5-2 wt %, and after being fully dissolved, it is filtered through a 0.45 μm filter membrane, and the filtrate is collected;

[0026] Finally, a pH regulator and an osmotic pressure regulator are added to the filtrate to adjust the pH to 7.5-8.2, and the osmotic pressure is adjusted to be equivalent to a sodium chloride solution with a concentration of 0.8-1.2%, thereby obtaining the eye drops for perioperative care in ophthalmology.

[0027] Compared with the prior art, the present invention has the following beneficial effects:

[0028] The invention discloses a composition for ophthalmic perioperative care. The composition has natural and easily available raw materials, does not contain antibiotics, hormones and preservatives, has little side effects and has good antibacterial and repair effects.

[0029] The present invention discloses a composition for ophthalmic perioperative care, wherein dandelion extract and honeysuckle extract are compounded, and it is found that the combination of dandelion extract and honeysuckle extract can completely and effectively inhibit the common pathogenic bacteria such as Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans, and the use of dandelion extract and honeysuckle extract alone cannot achieve the above effect; further, the present invention also modifies chitosan, and adds hyaluronic acid, astaxanthin, Tremella polysaccharide and glutathione components, and finally it can be seen from the embodiment that the above modification and addition of active ingredients greatly promote the repair effect of the eye drops made of the above composition on corneal damage after ophthalmic surgery. Compared with the prior art, the composition for ophthalmic perioperative care and the eye drops for ophthalmic perioperative care described in the present invention are all natural ingredients, do not contain antibiotics, hormones and preservatives, have good antibacterial and anti-inflammatory effects, have a good promoting effect on the repair of ophthalmic perioperative cornea, and have good application prospects.

[0030] In addition to the above-described objects, features and advantages, the present invention has other objects, features and advantages. The present invention is further described in detail below. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] The drawings constituting a part of this application are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. In the drawings:

[0032] Figure 1This is a comparison chart of the release amount of lactate dehydrogenase (LDH) (unit: IU / L) in the tears of the right eye before irradiation in the corneal damage repair test of the test example of the present invention;

[0033] Figure 2 This is a comparison chart of the release amount of lactate dehydrogenase (LDH) (unit: IU / L) in the tears of the right eye after 1 day of irradiation in a corneal injury repair test of a test example of the present invention;

[0034] Figure 3 This is a comparison chart of the release amount of lactate dehydrogenase (LDH) (unit: IU / L) in the tears of the right eye after irradiation for 3 days in a corneal injury repair test of a test example of the present invention;

[0035] Figure 4 This is a comparison chart of the release amount of lactate dehydrogenase (LDH) (unit: IU / L) in the tears of the right eye after 5 days of irradiation in the corneal damage repair test of the test example of the present invention. DETAILED DESCRIPTION

[0036] The embodiments of the present invention are described in detail below. The specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0037] A composition for ophthalmic perioperative care of the present invention comprises the following components in parts by weight:

[0038] 100 parts of chitosan, 5-10 parts of dandelion extract, 4-8 parts of honeysuckle extract, 3-6 parts of hyaluronic acid, 1-2 parts of astaxanthin, 1-2 parts of tremella polysaccharide and 1-1.5 parts of glutathione.

[0039] The dandelion extract is prepared by the following method:

[0040] S2.1 Water extraction: Take the dried whole dandelion, crush it and pass it through a 60-80 mesh sieve, add distilled water according to the solid-liquid ratio of 1g:25-35mL, soak at 50-70℃ for 30-40min, soak twice, filter, combine the filtrate, concentrate the filtrate 2-3 times, centrifuge and collect the supernatant;

[0041] S2.2 Preliminary purification: The supernatant was filtered through a 0.45 μm pore size filter membrane and ultrasonicated for 5 to 10 minutes, then applied to a pretreated D101 macroporous adsorption resin column, washed with water for 2 column volumes, eluted with 50% to 70% ethanol aqueous solution, the eluate was collected, and the eluate was concentrated 4 to 6 times;

[0042] S2.3 Purification again: The concentrated eluate was extracted with an equal volume of ethyl acetate, the extract was collected and concentrated 5 to 6 times, and then vacuum dried to obtain the dandelion extract.

[0043] The honeysuckle extract is prepared by the following method:

[0044] S3.1 Weigh the dried honeysuckle, add 60%-80% (V / V) ethanol solution, the amount of ethanol solution added is 4-8 times the weight of the dried honeysuckle (V / W), soak for 2-10 hours, heat and reflux for extraction 2-4 times, each reflux extraction for 1.5-3 hours, filter, collect the ethanol extract, adjust the pH of the filtrate to 5.5-8.5, let stand for 2-50 hours, filter, and concentrate the filtrate until there is no alcohol taste, to obtain a honeysuckle concentrate with a relative density of 1.05-1.4, wherein the relative density is measured at 60°C, and the concentration is vacuum concentration;

[0045] S3.2 Cool the honeysuckle concentrate to 4-35°C, filter, add 0.1-0.2 times (V / W) of the weight of dried honeysuckle to the filtrate for extraction, let stand for 0.5-12h, separate and remove the chloroform extract, and dry to obtain the honeysuckle extract, wherein the drying includes reduced pressure drying.

[0046] Preferably, the chitosan is secondary modified chitosan, and the specific modification steps of the secondary modified chitosan are as follows:

[0047] S1.1 Primary modification of chitosan: add a chitosan raw material with a deacetylation degree of 90-95% and an average molecular weight of 20000-25000Da and a hydrochloric acid solution with a mass fraction of 1-3% into a reaction container, wherein the mass volume ratio of the chitosan raw material to the hydrochloric acid solution is 1g:25-50mL; control the reaction temperature at 0-5°C in an ice-water bath; add soybean lecithin and dialdehyde starch under stirring; remove the ice-water bath after the addition is complete, and continue stirring the reaction at room temperature for 2-4h; obtain a primary modified chitosan by standing, precipitation, suction filtration, drying, and recrystallization; wherein the mass ratio of the chitosan raw material, soybean lecithin and dialdehyde starch is 1:(0.1-0.2):(0.02-0.3);

[0048] S1.2 Chitosan cross-linking: dissolve the primary modified chitosan in acetic acid solution to prepare a 60-100 mg / mL primary modified chitosan solution, and adjust the pH value to 5.5-6.5; drip 3-6 mg / mL sodium hexametaphosphate solution dropwise into the modified chitosan solution at a volume ratio of 1:(1.0-1.5), add a stabilizer at a final concentration of 2-20 mg / mL to form a cross-linked stable solution; obtain a secondary modified chitosan after standing, precipitation, filtration, drying, and recrystallization.

[0049] Example 1

[0050] A composition for ophthalmic perioperative care, comprising the following components by weight:

[0051] 100 parts of chitosan, 5 parts of dandelion extract, 4 parts of honeysuckle extract, 3 parts of hyaluronic acid, 1 part of astaxanthin, 1 part of tremella polysaccharide and 1 part of glutathione.

[0052] The dandelion extract is prepared by the following method:

[0053] S2.1 Water extraction: Take the dried whole dandelion, crush it and pass it through a 60-80 mesh sieve, add distilled water at a solid-liquid ratio of 1g:30mL, extract at 60℃ for 35min, extract twice, filter, combine the filtrate, concentrate the filtrate 2-3 times, centrifuge and collect the supernatant;

[0054] S2.2 Preliminary purification: The supernatant was filtered through a 0.45 μm pore size filter membrane and ultrasonicated for 5 to 10 minutes, then applied to a pretreated D101 macroporous adsorption resin column, washed with water for 2 column volumes, eluted with 60% ethanol aqueous solution, the eluate was collected, and the eluate was concentrated 4 to 6 times;

[0055] S2.3 Purification again: The concentrated eluate was extracted with an equal volume of ethyl acetate, the extract was collected and concentrated 5 to 6 times, and then vacuum dried to obtain the dandelion extract.

[0056] Pretreatment of D101 macroporous adsorption resin column: first soak the macroporous adsorption resin in a 3-5% by mass NaOH aqueous solution for 12 hours, then wash with pure water until the pH of the effluent is 8-9, then soak the macroporous adsorption resin in a 3-5% by mass HCL aqueous solution for 12 hours, then wash with pure water until the pH of the effluent is 7, to obtain the pretreated macroporous adsorption resin.

[0057] The honeysuckle extract is prepared by the following method:

[0058] S3.1 Weigh the dried honeysuckle, add 70% (V / V) ethanol solution, the amount of ethanol solution added is 6 times the weight of the dried honeysuckle (V / W), soak for 5 hours, heat and reflux for extraction 2-4 times, each reflux extraction for 1.5-3 hours, filter, collect the ethanol extract, adjust the pH of the filtrate to 7.0, let stand for 24 hours, filter, and concentrate the filtrate until there is no alcohol taste, to obtain a honeysuckle concentrate with a relative density of 1.2, wherein the relative density is measured at 60°C, and the concentration is vacuum concentration;

[0059] S3.2 Cool the honeysuckle concentrate to 4°C, filter it, add 0.5 times the weight of dried honeysuckle (V / W) of chloroform to the filtrate for extraction, let it stand for 6 hours, separate and remove the chloroform extract, and dry it to obtain the honeysuckle extract, wherein the drying includes drying under reduced pressure.

[0060] Example 2

[0061] A composition for ophthalmic perioperative care, comprising the following components by weight:

[0062] 100 parts of chitosan, 7 parts of dandelion extract, 6 parts of honeysuckle extract, 5 parts of hyaluronic acid, 1.5 parts of astaxanthin, 1.5 parts of tremella polysaccharide and 1.25 parts of glutathione.

[0063] The dandelion extract is prepared by the following method:

[0064] S2.1 Water extraction: Take the dried whole dandelion, crush it and pass it through a 60-80 mesh sieve, add distilled water at a solid-liquid ratio of 1g:30mL, extract at 60℃ for 35min, extract twice, filter, combine the filtrate, concentrate the filtrate 2-3 times, centrifuge and collect the supernatant;

[0065] S2.2 Preliminary purification: The supernatant was filtered through a 0.45 μm pore size filter membrane and ultrasonicated for 5 to 10 minutes, then applied to a pretreated D101 macroporous adsorption resin column, washed with water for 2 column volumes, eluted with 60% ethanol aqueous solution, the eluate was collected, and the eluate was concentrated 4 to 6 times;

[0066] S2.3 Purification again: The concentrated eluate was extracted with an equal volume of ethyl acetate, the extract was collected and concentrated 5 to 6 times, and then vacuum dried to obtain the dandelion extract.

[0067] The honeysuckle extract is prepared by the following method:

[0068] S3.1 Weigh the dried honeysuckle, add 70% (V / V) ethanol solution, the amount of ethanol solution added is 6 times the weight of the dried honeysuckle (V / W), soak for 5 hours, heat and reflux for extraction 2-4 times, each reflux extraction for 1.5-3 hours, filter, collect the ethanol extract, adjust the pH of the filtrate to 7.0, let stand for 24 hours, filter, and concentrate the filtrate until there is no alcohol taste, to obtain a honeysuckle concentrate with a relative density of 1.2, wherein the relative density is measured at 60°C, and the concentration is vacuum concentration;

[0069] S3.2 Cool the honeysuckle concentrate to 4°C, filter it, add 0.5 times the weight of dried honeysuckle (V / W) of chloroform to the filtrate for extraction, let it stand for 6 hours, separate and remove the chloroform extract, and dry it to obtain the honeysuckle extract, wherein the drying includes drying under reduced pressure.

[0070] Example 3

[0071] A composition for ophthalmic perioperative care, comprising the following components by weight:

[0072] 100 parts of chitosan, 10 parts of dandelion extract, 8 parts of honeysuckle extract, 6 parts of hyaluronic acid, 2 parts of astaxanthin, 2 parts of tremella polysaccharide and 1.5 parts of glutathione.

[0073] The dandelion extract is prepared by the following method:

[0074] S2.1 Water extraction: Take the dried whole dandelion, crush it and pass it through a 60-80 mesh sieve, add distilled water at a solid-liquid ratio of 1g:30mL, extract at 60℃ for 35min, extract twice, filter, combine the filtrate, concentrate the filtrate 2-3 times, centrifuge and collect the supernatant;

[0075] S2.2 Preliminary purification: The supernatant was filtered through a 0.45 μm pore size filter membrane and ultrasonicated for 5 to 10 minutes, then applied to a pretreated D101 macroporous adsorption resin column, washed with water for 2 column volumes, eluted with 60% ethanol aqueous solution, the eluate was collected, and the eluate was concentrated 4 to 6 times;

[0076] S2.3 Purification again: The concentrated eluate was extracted with an equal volume of ethyl acetate, the extract was collected and concentrated 5 to 6 times, and then vacuum dried to obtain the dandelion extract.

[0077] The honeysuckle extract is prepared by the following method:

[0078] S3.1 Weigh the dried honeysuckle, add 70% (V / V) ethanol solution, the amount of ethanol solution added is 6 times the weight of the dried honeysuckle (V / W), soak for 5 hours, heat and reflux for extraction 2-4 times, each reflux extraction for 1.5-3 hours, filter, collect the ethanol extract, adjust the pH of the filtrate to 7.0, let stand for 24 hours, filter, and concentrate the filtrate until there is no alcohol taste, to obtain a honeysuckle concentrate with a relative density of 1.2, wherein the relative density is measured at 60°C, and the concentration is vacuum concentration;

[0079] S3.2 Cool the honeysuckle concentrate to 4°C, filter it, add 0.5 times the weight of dried honeysuckle (V / W) of chloroform to the filtrate for extraction, let it stand for 6 hours, separate and remove the chloroform extract, and dry it to obtain the honeysuckle extract, wherein the drying includes drying under reduced pressure.

[0080] Example 4

[0081] A composition for ophthalmic perioperative care, comprising the following components by weight:

[0082] 100 parts of chitosan, 7 parts of dandelion extract, 6 parts of honeysuckle extract, 5 parts of hyaluronic acid, 1.5 parts of astaxanthin, 1.5 parts of tremella polysaccharide and 1.25 parts of glutathione.

[0083] The dandelion extract is prepared by the following method:

[0084] S2.1 Water extraction: Take the dried whole dandelion, crush it and pass it through a 60-80 mesh sieve, add distilled water at a solid-liquid ratio of 1g:30mL, extract at 60℃ for 35min, extract twice, filter, combine the filtrate, concentrate the filtrate 2-3 times, centrifuge and collect the supernatant;

[0085] S2.2 Preliminary purification: The supernatant was filtered through a 0.45 μm pore size filter membrane and ultrasonicated for 5 to 10 minutes, then applied to a pretreated D101 macroporous adsorption resin column, washed with water for 2 column volumes, eluted with 60% ethanol aqueous solution, the eluate was collected, and the eluate was concentrated 4 to 6 times;

[0086] S2.3 Purification again: The concentrated eluate was extracted with an equal volume of ethyl acetate, the extract was collected and concentrated 5 to 6 times, and then vacuum dried to obtain the dandelion extract.

[0087] The honeysuckle extract is prepared by the following method:

[0088] S3.1 Weigh the dried honeysuckle, add 70% (V / V) ethanol solution, the amount of ethanol solution added is 6 times the weight of the dried honeysuckle (V / W), soak for 5 hours, heat and reflux for extraction 2-4 times, each reflux extraction for 1.5-3 hours, filter, collect the ethanol extract, adjust the pH of the filtrate to 7.0, let stand for 24 hours, filter, and concentrate the filtrate until there is no alcohol taste, to obtain a honeysuckle concentrate with a relative density of 1.2, wherein the relative density is measured at 60°C, and the concentration is vacuum concentration;

[0089] S3.2 Cool the honeysuckle concentrate to 4°C, filter it, add 0.5 times the weight of dried honeysuckle (V / W) of chloroform to the filtrate for extraction, let it stand for 6 hours, separate and remove the chloroform extract, and dry it to obtain the honeysuckle extract, wherein the drying includes drying under reduced pressure.

[0090] The chitosan is secondary modified chitosan, and the specific modification steps of the secondary modified chitosan are as follows:

[0091] S1.1 Primary modification of chitosan: chitosan raw material with a deacetylation degree of 90-95% and an average molecular weight of 20000-25000Da and a 2% hydrochloric acid solution are added to a reaction container, wherein the mass volume ratio of the chitosan raw material to the hydrochloric acid solution is 1g:35mL; the reaction temperature is controlled at 0-5°C in an ice-water bath; soybean lecithin and dialdehyde starch are added under stirring; after the addition is completed, the ice-water bath is removed, and the reaction is continued under stirring for 3 hours at room temperature; after standing, precipitation, suction filtration, drying, and recrystallization, a primary modified chitosan is obtained; wherein the mass ratio of the chitosan raw material, soybean lecithin and dialdehyde starch is 1:0.15:0.1;

[0092] S1.2 Chitosan cross-linking: dissolve the primary modified chitosan in acetic acid solution to prepare 60-100 mg / mL primary modified chitosan solution, and adjust the pH value to 5.5-6.5; drip 5 mg / mL sodium hexametaphosphate solution into the modified chitosan solution drop by drop at a volume ratio of 1:1.2, add sodium carboxymethyl cellulose as a stabilizer at a final concentration of 10 mg / mL to form a cross-linked stable solution; obtain the secondary modified chitosan after standing, precipitation, filtration, drying and recrystallization.

[0093] The present invention also provides the use of the composition for ophthalmic perioperative care according to any one of the aforementioned embodiments 1 to 4, for preparing eye drops for ophthalmic perioperative care.

[0094] Comparative Example 1

[0095] A composition for ophthalmic perioperative care, comprising the following components by weight:

[0096] 100 parts of chitosan, 6 parts of honeysuckle extract, 5 parts of hyaluronic acid, 1.5 parts of astaxanthin, 1.5 parts of tremella polysaccharide and 1.25 parts of glutathione.

[0097] The honeysuckle extract is prepared by the following method:

[0098] S3.1 Weigh the dried honeysuckle, add 70% (V / V) ethanol solution, the amount of ethanol solution added is 6 times the weight of the dried honeysuckle (V / W), soak for 5 hours, heat and reflux for extraction 2-4 times, each reflux extraction for 1.5-3 hours, filter, collect the ethanol extract, adjust the pH of the filtrate to 7.0, let stand for 24 hours, filter, and concentrate the filtrate until there is no alcohol taste, to obtain a honeysuckle concentrate with a relative density of 1.2, wherein the relative density is measured at 60°C, and the concentration is vacuum concentration;

[0099] S3.2 Cool the honeysuckle concentrate to 4°C, filter it, add 0.5 times the weight of dried honeysuckle (V / W) of chloroform to the filtrate for extraction, let it stand for 6 hours, separate and remove the chloroform extract, and dry it to obtain the honeysuckle extract, wherein the drying includes drying under reduced pressure.

[0100] Comparative Example 1 does not contain dandelion extract, and the rest is the same as Example 2.

[0101] Comparative Example 2

[0102] A composition for ophthalmic perioperative care, comprising the following components by weight:

[0103] 100 parts of chitosan, 7 parts of dandelion extract, 5 parts of hyaluronic acid, 1.5 parts of astaxanthin, 1.5 parts of tremella polysaccharide and 1.25 parts of glutathione.

[0104] The dandelion extract is prepared by the following method:

[0105] S2.1 Water extraction: Take the dried whole dandelion, crush it and pass it through a 60-80 mesh sieve, add distilled water at a solid-liquid ratio of 1g:30mL, extract at 60℃ for 35min, extract twice, filter, combine the filtrate, concentrate the filtrate 2-3 times, centrifuge and collect the supernatant;

[0106] S2.2 Preliminary purification: The supernatant was filtered through a 0.45 μm pore size filter membrane and ultrasonicated for 5 to 10 minutes, then applied to a pretreated D101 macroporous adsorption resin column, washed with water for 2 column volumes, eluted with 60% ethanol aqueous solution, the eluate was collected, and the eluate was concentrated 4 to 6 times;

[0107] S2.3 Purification again: The concentrated eluate was extracted with an equal volume of ethyl acetate, the extract was collected and concentrated 5 to 6 times, and then vacuum dried to obtain the dandelion extract.

[0108] Comparative Example 2 does not contain honeysuckle extract, and the rest is the same as Example 2.

[0109] Comparative Example 3

[0110] A composition for ophthalmic perioperative care, comprising the following components by weight:

[0111] 100 parts of chitosan, 7 parts of dandelion extract, and 6 parts of honeysuckle extract.

[0112] The dandelion extract is prepared by the following method:

[0113] S2.1 Water extraction: Take the dried whole dandelion, crush it and pass it through a 60-80 mesh sieve, add distilled water at a solid-liquid ratio of 1g:30mL, extract at 60℃ for 35min, extract twice, filter, combine the filtrate, concentrate the filtrate 2-3 times, centrifuge and collect the supernatant;

[0114] S2.2 Preliminary purification: The supernatant was filtered through a 0.45 μm pore size filter membrane and ultrasonicated for 5 to 10 minutes, then applied to a pretreated D101 macroporous adsorption resin column, washed with water for 2 column volumes, eluted with 60% ethanol aqueous solution, the eluate was collected, and the eluate was concentrated 4 to 6 times;

[0115] S2.3 Purification again: The concentrated eluate was extracted with an equal volume of ethyl acetate, the extract was collected and concentrated 5 to 6 times, and then vacuum dried to obtain the dandelion extract.

[0116] The honeysuckle extract is prepared by the following method:

[0117] S3.1 Weigh the dried honeysuckle, add 70% (V / V) ethanol solution, the amount of ethanol solution added is 6 times the weight of the dried honeysuckle (V / W), soak for 5 hours, heat and reflux for extraction 2-4 times, each reflux extraction for 1.5-3 hours, filter, collect the ethanol extract, adjust the pH of the filtrate to 7.0, let stand for 24 hours, filter, and concentrate the filtrate until there is no alcohol taste, to obtain a honeysuckle concentrate with a relative density of 1.2, wherein the relative density is measured at 60°C, and the concentration is vacuum concentration;

[0118] S3.2 Cool the honeysuckle concentrate to 4°C, filter it, add 0.5 times the weight of dried honeysuckle (V / W) of chloroform to the filtrate for extraction, let it stand for 6 hours, separate and remove the chloroform extract, and dry it to obtain the honeysuckle extract, wherein the drying includes drying under reduced pressure.

[0119] Comparative Example 3 does not contain hyaluronic acid, astaxanthin, Tremella polysaccharide and glutathione, and the rest is the same as Example 2.

[0120] Comparative Example 4

[0121] A composition for ophthalmic perioperative care, comprising the following components by weight:

[0122] 100 parts of chitosan, 7 parts of dandelion extract, 6 parts of honeysuckle extract, 5 parts of hyaluronic acid, 1.5 parts of astaxanthin and 1.25 parts of glutathione.

[0123] The dandelion extract is prepared by the following method:

[0124] S2.1 Water extraction: Take the dried whole dandelion, crush it and pass it through a 60-80 mesh sieve, add distilled water at a solid-liquid ratio of 1g:30mL, extract at 60℃ for 35min, extract twice, filter, combine the filtrate, concentrate the filtrate 2-3 times, centrifuge and collect the supernatant;

[0125] S2.2 Preliminary purification: The supernatant was filtered through a 0.45 μm pore size filter membrane and ultrasonicated for 5 to 10 minutes, then applied to a pretreated D101 macroporous adsorption resin column, washed with water for 2 column volumes, eluted with 60% ethanol aqueous solution, the eluate was collected, and the eluate was concentrated 4 to 6 times;

[0126] S2.3 Purification again: The concentrated eluate was extracted with an equal volume of ethyl acetate, the extract was collected and concentrated 5 to 6 times, and then vacuum dried to obtain the dandelion extract.

[0127] The honeysuckle extract is prepared by the following method:

[0128] S3.1 Weigh the dried honeysuckle, add 70% (V / V) ethanol solution, the amount of ethanol solution added is 6 times the weight of the dried honeysuckle (V / W), soak for 5 hours, heat and reflux for extraction 2-4 times, each reflux extraction for 1.5-3 hours, filter, collect the ethanol extract, adjust the pH of the filtrate to 7.0, let stand for 24 hours, filter, and concentrate the filtrate until there is no alcohol taste, to obtain a honeysuckle concentrate with a relative density of 1.2, wherein the relative density is measured at 60°C, and the concentration is vacuum concentration;

[0129] S3.2 Cool the honeysuckle concentrate to 4°C, filter it, add 0.5 times the weight of dried honeysuckle (V / W) of chloroform to the filtrate for extraction, let it stand for 6 hours, separate and remove the chloroform extract, and dry it to obtain the honeysuckle extract, wherein the drying includes drying under reduced pressure.

[0130] Comparative Example 4 does not contain Tremella polysaccharide, and the rest is the same as Example 2.

[0131] Comparative Example 5

[0132] A composition for ophthalmic perioperative care, comprising the following components by weight:

[0133] 100 parts of chitosan, 7 parts of dandelion extract, 6 parts of honeysuckle extract, 5 parts of hyaluronic acid, 1.5 parts of astaxanthin and 1.5 parts of tremella polysaccharide.

[0134] The dandelion extract is prepared by the following method:

[0135] S2.1 Water extraction: Take the dried whole dandelion, crush it and pass it through a 60-80 mesh sieve, add distilled water at a solid-liquid ratio of 1g:30mL, extract at 60℃ for 35min, extract twice, filter, combine the filtrate, concentrate the filtrate 2-3 times, centrifuge and collect the supernatant;

[0136] S2.2 Preliminary purification: The supernatant was filtered through a 0.45 μm pore size filter membrane and ultrasonicated for 5 to 10 minutes, then applied to a pretreated D101 macroporous adsorption resin column, washed with water for 2 column volumes, eluted with 60% ethanol aqueous solution, the eluate was collected, and the eluate was concentrated 4 to 6 times;

[0137] S2.3 Purification again: The concentrated eluate was extracted with an equal volume of ethyl acetate, the extract was collected and concentrated 5 to 6 times, and then vacuum dried to obtain the dandelion extract.

[0138] The honeysuckle extract is prepared by the following method:

[0139] S3.1 Weigh the dried honeysuckle, add 70% (V / V) ethanol solution, the amount of ethanol solution added is 6 times the weight of the dried honeysuckle (V / W), soak for 5 hours, heat and reflux for extraction 2-4 times, each reflux extraction for 1.5-3 hours, filter, collect the ethanol extract, adjust the pH of the filtrate to 7.0, let stand for 24 hours, filter, and concentrate the filtrate until there is no alcohol taste, to obtain a honeysuckle concentrate with a relative density of 1.2, wherein the relative density is measured at 60°C, and the concentration is vacuum concentration;

[0140] S3.2 Cool the honeysuckle concentrate to 4°C, filter it, add 0.5 times the weight of dried honeysuckle (V / W) of chloroform to the filtrate for extraction, let it stand for 6 hours, separate and remove the chloroform extract, and dry it to obtain the honeysuckle extract, wherein the drying includes drying under reduced pressure.

[0141] Comparative Example 5 does not contain glutathione, and the rest is the same as Example 2.

[0142] The present invention also provides an eye drop for ophthalmic perioperative care, comprising any one of the compositions for ophthalmic perioperative care in Examples 1-4 and sterile water. Preferably, the remainder of the eye drop other than the composition for ophthalmic perioperative care is sterile water.

[0143] The present invention also provides a method for preparing eye drops for ophthalmic perioperative care:

[0144] First, chitosan, dandelion extract, honeysuckle extract, hyaluronic acid, astaxanthin, tremella polysaccharide, and glutathione in the formulated amounts are uniformly mixed, and crushed through a 200-mesh sieve to obtain a first mixture;

[0145] Then, the first mixture is added into sterile water at 0.5-2 wt %, and after being fully dissolved, it is filtered through a 0.45 μm filter membrane, and the filtrate is collected;

[0146] Finally, a pH regulator and an osmotic pressure regulator are added to the filtrate to adjust the pH to 7.5-8.2, and the osmotic pressure is adjusted to be equivalent to a sodium chloride solution with a concentration of 0.8-1.2%, thereby obtaining the eye drops for perioperative care in ophthalmology.

[0147] Eye drops test example:

[0148] The compositions of Examples 1-4 and Comparative Examples 1-5 were prepared into eye drops for ophthalmic perioperative care according to the following preparation methods:

[0149] 1) uniformly mixing the ingredients of the formulated raw materials, and crushing them through a 200-mesh sieve to obtain a first mixture;

[0150] 2) adding 1 wt % of the first mixture into sterile water, filtering through a 0.45 μm filter membrane after fully dissolving, and collecting the filtrate;

[0151] 3) Adding a pH regulator and an osmotic pressure regulator to the filtrate, adjusting the pH to 7.6, and adjusting the osmotic pressure to be equivalent to a sodium chloride solution with a concentration of 0.9%, to obtain eye drops for perioperative care in ophthalmology.

[0152] (1) Antibacterial effect test:

[0153] The antibacterial effects of the antibacterial agents were investigated using turbidity method with Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans as test bacteria.

[0154] Preparation of bacterial suspension: Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa were inoculated into 10 ml of nutrient broth medium under sterile conditions and cultured at 35°C for 24 hours. The bacterial suspension was diluted with sterile saline to a concentration of 10 6 cfu / ml. Candida albicans was inoculated into 10 ml of modified Martin liquid medium under sterile conditions and cultured at 25°C for 48 h. The bacterial suspension was diluted with sterile saline to a concentration of 10 6 cfu / ml.

[0155] Preparation of test solution: Take 5 ml of eye drops prepared in Examples 1-4 and Comparative Examples 1-3, respectively, and dissolve them in 100 ml of nutrient broth medium for testing Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. Take 5 ml of eye drops for perioperative care in ophthalmology prepared in Examples 1-4 and Comparative Examples 1-3, respectively, and dissolve them in 100 ml of modified Martin liquid medium for testing Candida albicans.

[0156] Take 10 ml of the test solution into a test tube and sterilize it by high pressure. Set up two test solution tubes for each test bacteria and a set of control tubes.

[0157] Under sterile conditions, 0.2 ml of bacterial suspension was added to each test tube. Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa were cultured at 35°C for 24 hours, and Candida albicans was cultured at 25°C for 48 hours. Observe whether the solution in the test tube is clear. The experimental results are shown in Table 1.

[0158] Table 1 Antibacterial effect test results

[0159] Escherichia coli Staphylococcus aureus Pseudomonas aeruginosa Candida albicans Example 1 - - - - Example 2 - - - - Example 3 - - - - Example 4 - - - - Comparative Example 1 + - - + Comparative Example 2 - + - + Comparative Example 3 - - - -

[0160] The data results of Examples 1-4 and Comparative Examples 1-3 show that the combination of dandelion extract and honeysuckle extract can completely and effectively inhibit common pathogenic bacteria such as Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans. The above effects cannot be achieved by using dandelion extract or honeysuckle extract alone.

[0161] (2) Corneal damage repair test:

[0162] Forty healthy adult New Zealand white rabbits of either sex were divided into eight groups and their corneas were irradiated with ultraviolet light (UV-B) for 10 minutes (750-800 μw / cm 2 ). Each group was treated with the eye drops prepared in Examples 2 and 4, Comparative Examples 1-5, and the control example (Example 2 in patent document CN202010951511.7) in the right eye, 0.1 mL each time, 4 times a day, for 5 consecutive days, and the left eye was not treated.

[0163] The degree of corneal damage repair was determined by measuring the release of lactate dehydrogenase (LDH) in tears. An increase in LDH release indicates corneal damage, and a decrease in LDH release indicates corneal damage has been repaired. The LDH release of each group was measured before irradiation, 1 day after irradiation, 3 days after irradiation, and 5 days after irradiation, and the average value was taken for each group.

[0164] LDH measurement method: 250 μl of saline solution was applied to the eyes for 1 minute, and then 50 μl of the sample was taken to measure the LDH release using an automatic biochemical analyzer. The results are shown in Table 2 and Figure 1-Figure 4 shown.

[0165] Table 2 Corneal damage repair test results (unit: IU / L)

[0166]

[0167] From the comparison of the data of Example 2 and Example 4 in Table 2, it can be found that Example 4, which modified chitosan, has a significantly better repair effect on corneal damage than Example 2, which is not modified; further, from the comparison of Example 2 with Comparative Examples 1-5, it can be found that Comparative Example 3, which does not contain hyaluronic acid, astaxanthin, Tremella polysaccharide and glutathione, has a significantly poorer repair effect on corneal damage, and is far worse than Example 4. From the comparison of the data of Examples 2 and 4 with the control example, it can be seen that the composition of the present invention is better than the control example containing ectoine in repairing postoperative corneal damage.

[0168] It can be seen from the above test examples that the present invention discloses a composition for ophthalmic perioperative care, and dandelion extract and honeysuckle extract are compounded. It is found that the combination of dandelion extract and honeysuckle extract can completely and effectively inhibit the common pathogens such as Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans. The use of dandelion extract and honeysuckle extract alone cannot achieve the above effect; further, the present invention also modifies chitosan, and adds hyaluronic acid, astaxanthin, Tremella polysaccharide and glutathione components. Finally, it can be seen from the embodiment that the above modification and addition of active ingredients greatly promote the repair effect of the eye drops made from the above composition on ophthalmic perioperative corneal damage. Compared with the prior art, the raw materials of the composition described in the present invention are easy to obtain and the ingredients are natural; the eye drops used for ophthalmic perioperative care do not contain antibiotics, hormones and preservatives, have good antibacterial and anti-inflammatory effects, have a good promoting effect on the repair of ophthalmic perioperative cornea, and have good application prospects.

[0169] The above contents are further detailed descriptions of the present invention in combination with specific preferred embodiments, and it cannot be determined that the specific implementation of the present invention is limited to these descriptions. For ordinary technicians in the technical field to which the present invention belongs, several simple deductions and substitutions can be made without departing from the concept of the present invention, which should be regarded as belonging to the protection scope of the present invention.

Claims

1. A composition for ophthalmic perioperative care, characterized in that: The following ingredients are included by weight: 100 parts of chitosan, 5-10 parts of dandelion extract, 4-8 parts of honeysuckle extract, 3-6 parts of hyaluronic acid, 1-2 parts of astaxanthin, 1-2 parts of tremella polysaccharide and 1-1.5 parts of glutathione.

2. The composition for ophthalmic perioperative care according to claim 1, characterized in that: The chitosan is secondary modified chitosan, and the specific modification steps of the secondary modified chitosan are as follows: S1.1 Primary modification of chitosan: add a chitosan raw material with a deacetylation degree of 90-95% and an average molecular weight of 20000-25000Da and a hydrochloric acid solution with a mass fraction of 1-3% into a reaction container, wherein the mass volume ratio of the chitosan raw material to the hydrochloric acid solution is 1g:25-50mL; control the reaction temperature at 0-5°C in an ice-water bath; add soybean lecithin and dialdehyde starch under stirring; remove the ice-water bath after the addition is complete, and continue stirring the reaction at room temperature for 2-4h; obtain a primary modified chitosan by standing, precipitation, suction filtration, drying, and recrystallization; wherein the mass ratio of the chitosan raw material, soybean lecithin and dialdehyde starch is 1:(0.1-0.2):(0.02-0.3); S1.2 Chitosan cross-linking: dissolve the primary modified chitosan in acetic acid solution to prepare a 60-100 mg / mL primary modified chitosan solution, and adjust the pH value to 5.5-6.5; drip 3-6 mg / mL sodium hexametaphosphate solution dropwise into the modified chitosan solution at a volume ratio of 1:(1.0-1.5), add a stabilizer at a final concentration of 2-20 mg / mL to form a cross-linked stable solution; obtain a secondary modified chitosan after standing, precipitation, filtration, drying, and recrystallization.

3. The composition for ophthalmic perioperative care according to claim 1, characterized in that: The dandelion extract is prepared by the following method: S2.1 Water extraction: Take the dried whole dandelion, crush it and pass it through a 60-80 mesh sieve, add distilled water according to the solid-liquid ratio of 1g:25-35mL, soak at 50-70℃ for 30-40min, soak twice, filter, combine the filtrate, concentrate the filtrate 2-3 times, centrifuge and collect the supernatant; S2.2 Preliminary purification: The supernatant was filtered through a 0.45 μm pore size filter membrane and ultrasonicated for 5 to 10 minutes, then applied to a pretreated D101 macroporous adsorption resin column, washed with water for 2 column volumes, eluted with 50% to 70% ethanol aqueous solution, the eluate was collected, and the eluate was concentrated 4 to 6 times; S2.3 Purification again: The concentrated eluate was extracted with an equal volume of ethyl acetate, the extract was collected and concentrated 5 to 6 times, and then vacuum dried to obtain the dandelion extract.

4. The composition for ophthalmic perioperative care according to claim 1, characterized in that: The honeysuckle extract is prepared by the following method: S3.1 Weigh the dried honeysuckle, add 60%-80% (V / V) ethanol solution, the amount of ethanol solution added is 4-8 times the weight of the dried honeysuckle (V / W), soak for 2-10 hours, heat and reflux for extraction 2-4 times, each reflux extraction for 1.5-3 hours, filter, collect the ethanol extract, adjust the pH of the filtrate to 5.5-8.5, let stand for 2-50 hours, filter, and concentrate the filtrate until there is no alcohol taste, to obtain a honeysuckle concentrate with a relative density of 1.05-1.4, wherein the relative density is measured at 60°C, and the concentration is vacuum concentration; S3.2 Cool the honeysuckle concentrate to 4-35°C, filter, add 0.1-0.2 times (V / W) of the weight of dried honeysuckle to the filtrate for extraction, let stand for 0.5-12h, separate and remove the chloroform extract, and dry to obtain the honeysuckle extract, wherein the drying includes reduced pressure drying.

5. The use of the composition for ophthalmic perioperative care according to any one of claims 1 to 4, characterized in that: Used to prepare eye drops for perioperative care in ophthalmology.

6. The use of the composition for ophthalmic perioperative care according to claim 5, characterized in that: The ophthalmic perioperative period refers to the perioperative period of ophthalmic cataract surgery.

7. An eye drop for perioperative care in ophthalmology, characterized in that: The invention comprises sterile water and a composition for ophthalmic perioperative care as claimed in any one of claims 1 to 4.

8. The eye drops for ophthalmic perioperative care according to claim 7, characterized in that: In the eye drops for ophthalmic perioperative care, the mass fraction of the composition for ophthalmic perioperative care is 0.5-2%.

9. The method for preparing eye drops for ophthalmic perioperative care according to any one of claims 7 to 8, characterized in that: The following steps are involved: First, chitosan, dandelion extract, honeysuckle extract, hyaluronic acid, astaxanthin, tremella polysaccharide, and glutathione in the formulated amounts are uniformly mixed, and crushed through a 200-mesh sieve to obtain a first mixture; Then, the first mixture is added into sterile water at 0.5-2 wt %, and after being fully dissolved, it is filtered through a 0.45 μm filter membrane, and the filtrate is collected; Finally, a pH regulator and an osmotic pressure regulator are added to the filtrate to adjust the pH to 7.5-8.2, and the osmotic pressure is adjusted to be equivalent to a sodium chloride solution with a concentration of 0.8-1.2%, thereby obtaining the eye drops for perioperative care in ophthalmology.

Citation Information

Patent Citations

  • Eye care composition as well as preparation method and application thereof

    CN111991415A

  • Eye disease ointment for pets and preparation method of eye disease ointment

    CN107691854A

  • Application of tremella polysaccharide extract in preparation of medicine capable of treating xerophthalmia

    CN109758473A

  • Preparation method and application of chitosan material suitable for mucous membrane administration

    CN115819853A

  • Composition for improving eye microcirculation and application thereof

    CN117838597A

Cited By

  • Herbal compound-containing antibacterial eye drops for pets and preparation method of herbal compound-containing antibacterial eye drops

    CN119235948A